Medistim — Director's Dealing 2020

Jan 22, 2020

Transfer of shares to CEO Medistim ASA

Transfer of shares to CEO Medistim ASA

Medistim ASA has transferred 10,000 shares to Medistim CEO Kari Krogstad. It is part of her agreement with the Board of Medistim that she receives 10,000 shares. The agreement has been previously described in the Company's Annual Report. Medistims last traded share price in 2019 was 193.00 so the shares are transferred at this cost. Medistim ASA has 148,500 own shares and after the transfer to Kari Krogstad the company has 138,500 own shares shares. Kari Krogstad has after the latest transfer 132,500 shares in Medistim ASA.